T. Rowe Price Investment Management
SHC icon

T. Rowe Price Investment Management’s Sotera Health SHC Stock Holding History

T. Rowe Price Investment Management’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131M Buy
9,125,621
+260,825
+3% +$4.33M 0.09% 214
2025
Q4 		$156M Sell
8,864,796
-354,197
-4% -$5.86M 0.1% 191
2025
Q3 		$145M Buy
9,218,993
+165,528
+2% +$2.32M 0.09% 221
2025
Q2 		$101M Buy
9,053,465
+1,007,963
+13% +$11.8M 0.06% 278
2025
Q1 		$93.8M Buy
8,045,502
+450,761
+6% +$5.8M 0.06% 290
2024
Q4 		$104M Sell
7,594,741
-1,823,250
-19% -$26.4M 0.06% 288
2024
Q3 		$157M Buy
9,417,991
+3,330,278
+55% +$48.6M 0.09% 219
2024
Q2 		$72.3M Buy
6,087,713
+1,050,848
+21% +$12M 0.05% 330
2024
Q1 		$60.5M Buy
5,036,865
+1,444,834
+40% +$21.5M 0.04% 362
2023
Q4 		$60.5M Buy
3,592,031
+331,327
+10% +$4.69M 0.04% 365
2023
Q3 		$48.8M Buy
3,260,704
+2,694,747
+476% +$45.5M 0.03% 366
2023
Q2 		$10.7M Buy
+565,957
New +$8.99M 0.01% 513

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management's SHC Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Sotera Health (SHC) stake by 2.9% in Q1 2026, buying an estimated $4.33M and bringing the position to 9,125,621 shares worth $131M. The position accounts for 0.09% of the portfolio, ranked #214.

T. Rowe Price Investment Management first reported a position in SHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $157M in Q3 2024. 298 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • T. Rowe Price Investment Management held 9,125,621 shares of Sotera Health worth $131M as of Q1 2026.
  • T. Rowe Price Investment Management bought 260,825 Sotera Health shares in Q1 2026, an estimated $4.33M.
  • Sotera Health made up 0.09% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #214 holding.
  • T. Rowe Price Investment Management first reported a position in Sotera Health in Q2 2023 and has held it in 12 quarters since.
  • T. Rowe Price Investment Management's Sotera Health position peaked at $157M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.